Mirum Pharmaceuticals

$22.25
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.51 (+2.35%) Today
$0.00 (0.00%) As of 7:00 AM EST after-hours

Why Robinhood?

You can buy or sell MIRM and other stocks, options, and ETFs commission-free!

About MIRM

Mirum Pharmaceuticals, Inc. Common Stock, also called Mirum Pharmaceuticals, is a biopharmaceutical company. The firm focuses on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. Its product candidates include Maralixibat and Volixibat. The company was founded by Niall O'Donnel, Michael Grey and Christopher Peetz on May 7, 2018 and is headquartered in Foster City, CA. The listed name for MIRM is Mirum Pharmaceuticals, Inc. Common Stock.

CEO
Christopher Peetz
Employees
33
Headquarters
Foster City, California
Founded
2018
Market Cap
572.20M
Price-Earnings Ratio
Dividend Yield
Average Volume
71.80K
High Today
$22.58
Low Today
$21.83
Open Price
$21.86
Volume
25.33K
52 Week High
$28.31
52 Week Low
$7.11

Collections

MIRM Earnings

-$5.31
-$3.54
-$1.77
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Mar 11, Pre-Market

You May Also Like